Skip to main content
Erschienen in:

01.04.2021 | Review

Where are the keys to improve vaccine uptake in adults and elders in European countries?

verfasst von: Jacques Gaillat

Erschienen in: Aging Clinical and Experimental Research | Ausgabe 4/2021

Einloggen, um Zugang zu erhalten

Abstract

Improving vaccination of the elderly is one of the most important challenges in the coming years, as it was for infant’s decades ago. Insufficient vaccine uptake in the elderly can be considered a concern with regard to the burden of vaccine preventable diseases in this growing population. The purpose of this paper is to have an overview on the different steps involved in decision policy making from the regulatory agencies until people are vaccinated. Examples of different policies within European countries will be compared for influenza, streptococcal and zoster infections. For each step, key improvements to increase vaccine uptake in this specific population will be proposed.
Literatur
2.
Zurück zum Zitat GBD 2016 (2018) Lower respiratory infections collaborators, estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study. Lancet Infect Dis 18:1191–1210CrossRef GBD 2016 (2018) Lower respiratory infections collaborators, estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study. Lancet Infect Dis 18:1191–1210CrossRef
4.
Zurück zum Zitat Sheikh S, Biundo E, Courcier S et al (2018) A report on the status of vaccination in Europe. Vaccine 36:4979–4992CrossRef Sheikh S, Biundo E, Courcier S et al (2018) A report on the status of vaccination in Europe. Vaccine 36:4979–4992CrossRef
5.
Zurück zum Zitat Poland GA, Shefer AM, McCauley M et al (2003) Standards for adult immunization practices standards for adult immunization practices. Am J Prev Med 25:144–150CrossRef Poland GA, Shefer AM, McCauley M et al (2003) Standards for adult immunization practices standards for adult immunization practices. Am J Prev Med 25:144–150CrossRef
6.
Zurück zum Zitat Poland GA, Jacobson RM, Ovsyannikova A (2009) Trends affecting the future of vaccine development and delivery: the role of demographics, regulatory science, the anti-vaccine movement, and vaccinomics. Vaccine 27:3240–3244CrossRef Poland GA, Jacobson RM, Ovsyannikova A (2009) Trends affecting the future of vaccine development and delivery: the role of demographics, regulatory science, the anti-vaccine movement, and vaccinomics. Vaccine 27:3240–3244CrossRef
8.
Zurück zum Zitat Gozalo PL, Pop-Vicas A, Feng Z et al (2012) The impact of influenza on the functional decline. J Am Geriatr Soc 60:1260–1267CrossRef Gozalo PL, Pop-Vicas A, Feng Z et al (2012) The impact of influenza on the functional decline. J Am Geriatr Soc 60:1260–1267CrossRef
12.
Zurück zum Zitat Modin D, Jørgensen ME, Gislason G et al (2019) Solomon SD4, Torp-Pedersen C1,2, biering-Sørensen T1 influenza vaccine in heart Failure. Traffic. 139:575–586 Modin D, Jørgensen ME, Gislason G et al (2019) Solomon SD4, Torp-Pedersen C1,2, biering-Sørensen T1 influenza vaccine in heart Failure. Traffic. 139:575–586
13.
Zurück zum Zitat Tan L (2014) Adult vaccination now is the time to realize an unfulfilled potential. Hum Vaccines Immunother 11:2158–2166CrossRef Tan L (2014) Adult vaccination now is the time to realize an unfulfilled potential. Hum Vaccines Immunother 11:2158–2166CrossRef
14.
Zurück zum Zitat Gemmil I (2019) Vaccines for adults: the time has come. Can Commun Dis Rep 41:2–5CrossRef Gemmil I (2019) Vaccines for adults: the time has come. Can Commun Dis Rep 41:2–5CrossRef
17.
Zurück zum Zitat Nohynek H, Wichmann O, Dancona F et al (2013) National advisory groups and their role in immunization policy-making processes in European countries. Microbiol Infect 19:1096–1105CrossRef Nohynek H, Wichmann O, Dancona F et al (2013) National advisory groups and their role in immunization policy-making processes in European countries. Microbiol Infect 19:1096–1105CrossRef
20.
Zurück zum Zitat Falkenhorst G, Remschmidt C, Harder T et al (2016) Background paper to the updated pneumococcal vaccination recommendation for older adults in Germany. Bundesgesundheitsbl 59:1623–1657. https://doi.org/10.1007/s00103-016-2466-9 Falkenhorst G, Remschmidt C, Harder T et al (2016) Background paper to the updated pneumococcal vaccination recommendation for older adults in Germany. Bundesgesundheitsbl 59:1623–1657. https://​doi.​org/​10.​1007/​s00103-016-2466-9
21.
Zurück zum Zitat Haut conseil de santé publique Avis relatif aux recommandations vaccinales contre les infections à pneumocoque pour les adultes 10 mars 2017. http://www.hcsp.fr Haut conseil de santé publique Avis relatif aux recommandations vaccinales contre les infections à pneumocoque pour les adultes 10 mars 2017. http://​www.​hcsp.​fr
22.
Zurück zum Zitat Waight PA, Andrews NJ, Ladhani SN et al (2015) Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study. Lancet Infect Dis 15:535–543CrossRef Waight PA, Andrews NJ, Ladhani SN et al (2015) Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study. Lancet Infect Dis 15:535–543CrossRef
23.
Zurück zum Zitat Reinert RR, Haupts S, van der Linden M et al (2005) Invasive pneumococcal disease in adults in North-Rhine Westphalia, Germany, 2001–2003. Clin Microbiol Infect 11:985–991CrossRef Reinert RR, Haupts S, van der Linden M et al (2005) Invasive pneumococcal disease in adults in North-Rhine Westphalia, Germany, 2001–2003. Clin Microbiol Infect 11:985–991CrossRef
25.
Zurück zum Zitat Casez P, Fauconnier J, Jorgensen L et al (2015) Longitudinal DRG-based survey of all-cause and pneumococcal pneumonia and meningitis for inpatients in France (2005–2010). Med Mal Inf 45:446–455CrossRef Casez P, Fauconnier J, Jorgensen L et al (2015) Longitudinal DRG-based survey of all-cause and pneumococcal pneumonia and meningitis for inpatients in France (2005–2010). Med Mal Inf 45:446–455CrossRef
26.
Zurück zum Zitat Health Protection Report Volume 11 Number 23–30 June 2017, Rodrigo. Eur Respir J 45:1632–1641 Health Protection Report Volume 11 Number 23–30 June 2017, Rodrigo. Eur Respir J 45:1632–1641
27.
Zurück zum Zitat Rieck T, Feig M, Eckmanns T et al (2014) Vaccination coverage among children in Germany estimated by analysis of health insurance claims data. Human Vaccines Immunother 10:476–484CrossRef Rieck T, Feig M, Eckmanns T et al (2014) Vaccination coverage among children in Germany estimated by analysis of health insurance claims data. Human Vaccines Immunother 10:476–484CrossRef
29.
Zurück zum Zitat van Hoek AJ, Melegaro A, Gay N et al (2012) Edmunds WJ The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom. Vaccine 30:1225–1234CrossRef van Hoek AJ, Melegaro A, Gay N et al (2012) Edmunds WJ The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom. Vaccine 30:1225–1234CrossRef
35.
Zurück zum Zitat Douglas J (2009). Opel et al., “Social marketing as a strategy to increase immunization rates,”. Arch Pediatr Adolesc Med 163: 432–437. https://doi.org/10.1001/archpediatrics.2009.42 Douglas J (2009). Opel et al., “Social marketing as a strategy to increase immunization rates,”. Arch Pediatr Adolesc Med 163: 432–437. https://​doi.​org/​10.​1001/​archpediatrics.​2009.​42
36.
Zurück zum Zitat Blank P, Schwenkglenks M, Szucs TD (2012) The impact of European vaccination policies on seasonal influenza vaccination coverage rates in the elderly. Hum Vaccin Immunother 8:328–335CrossRef Blank P, Schwenkglenks M, Szucs TD (2012) The impact of European vaccination policies on seasonal influenza vaccination coverage rates in the elderly. Hum Vaccin Immunother 8:328–335CrossRef
41.
Zurück zum Zitat Stefanoff P, Mamelund SE, Robinson M et al (2010) VACSATC working group on standardization of attitudinal studies in Europe. Tracking parental attitudes on vaccination across European countries: the Vaccine safety, attitudes, training and communication project (VACSATC). Vaccine 28:5731–5737. http://dx.doi.org/10.1016/j.vaccine.2010.06.009 Stefanoff P, Mamelund SE, Robinson M et al (2010) VACSATC working group on standardization of attitudinal studies in Europe. Tracking parental attitudes on vaccination across European countries: the Vaccine safety, attitudes, training and communication project (VACSATC). Vaccine 28:5731–5737. http://​dx.​doi.​org/​10.​1016/​j.​vaccine.​2010.​06.​009
42.
Zurück zum Zitat Kassianos G, Blank P, Falup-Pecurariu O et al (2016) Influenza vaccination: key factors for general practitioners in Europe—a synthesis by European experts based on national guidelines and best practices in the United Kingdom and the Netherlands drugs in context 5:212293. https://doi.org/10.7573/dic.212293 Kassianos G, Blank P, Falup-Pecurariu O et al (2016) Influenza vaccination: key factors for general practitioners in Europe—a synthesis by European experts based on national guidelines and best practices in the United Kingdom and the Netherlands drugs in context 5:212293. https://​doi.​org/​10.​7573/​dic.​212293
43.
Zurück zum Zitat Ammi M, Fortier G (2017) The influence of welfare systems on pay-for-performance programs for general practitioners: a critical review. Soc Sci Med 178:157e166 Ammi M, Fortier G (2017) The influence of welfare systems on pay-for-performance programs for general practitioners: a critical review. Soc Sci Med 178:157e166
44.
Zurück zum Zitat Isenor JE, O’Reilly BA, Bowles SK (2018) Evaluation of the impact of immunization policies, including the addition of pharmacists as immunizers, on influenza vaccination coverage in Nova Scotia, Canada: 2006–2016. BMC Public Health 18:787. https://doi.org/10.1186/s12889-018-5697-x Isenor JE, O’Reilly BA, Bowles SK (2018) Evaluation of the impact of immunization policies, including the addition of pharmacists as immunizers, on influenza vaccination coverage in Nova Scotia, Canada: 2006–2016. BMC Public Health 18:787. https://​doi.​org/​10.​1186/​s12889-018-5697-x
46.
Zurück zum Zitat Nowalk MP, Zimmerman RK, Cleary SM et al (2005) Missed opportunities to vaccinate older adults in primary care. J Am Board Fam Pract 18:20–27CrossRef Nowalk MP, Zimmerman RK, Cleary SM et al (2005) Missed opportunities to vaccinate older adults in primary care. J Am Board Fam Pract 18:20–27CrossRef
49.
Zurück zum Zitat Bedford H, Attwell K, Danchin M et al (2018) Vaccine hesitancy, refusal and access barriers: THE need for clarity in terminology. Vaccine 36:6556–6558 Bedford H, Attwell K, Danchin M et al (2018) Vaccine hesitancy, refusal and access barriers: THE need for clarity in terminology. Vaccine 36:6556–6558
53.
Zurück zum Zitat MacDonald NE (2015) Vaccine hesitancy: definition, scope and determinants. Vaccine 33:4161–4164CrossRef MacDonald NE (2015) Vaccine hesitancy: definition, scope and determinants. Vaccine 33:4161–4164CrossRef
54.
Zurück zum Zitat Dubé E, Vivion M, MacDonald NE (2015) Vaccine hesitancy, vaccine refusal ant the anti-vaccine movement: influence, impact, implications. Expert Rev Vaccines 14:99–117CrossRef Dubé E, Vivion M, MacDonald NE (2015) Vaccine hesitancy, vaccine refusal ant the anti-vaccine movement: influence, impact, implications. Expert Rev Vaccines 14:99–117CrossRef
55.
Zurück zum Zitat Kata A (2012) Anti-vaccine activists, Web 2.0, and the postmodern paradigm—an overview of tactics and tropes used online by the anti-vaccination movement. Vaccine 30:3778–3789CrossRef Kata A (2012) Anti-vaccine activists, Web 2.0, and the postmodern paradigm—an overview of tactics and tropes used online by the anti-vaccination movement. Vaccine 30:3778–3789CrossRef
56.
Zurück zum Zitat Dubé E, Gagnon D, MacDonald NE (2015) The SAGE working group on vaccine hesitancy. Vaccine 33:4191–4203CrossRef Dubé E, Gagnon D, MacDonald NE (2015) The SAGE working group on vaccine hesitancy. Vaccine 33:4191–4203CrossRef
57.
Zurück zum Zitat Gagneur A, Gosselin V, Dubé E (2018) Motivational interviewing: a promising tool to address vaccine hesitancy. Vaccine 36:6553–6555CrossRef Gagneur A, Gosselin V, Dubé E (2018) Motivational interviewing: a promising tool to address vaccine hesitancy. Vaccine 36:6553–6555CrossRef
58.
Zurück zum Zitat Parrish-Sprowl J (2018) Vaccine hesitancy communication: what counts as evidence? Vaccine 36:6529–6530CrossRef Parrish-Sprowl J (2018) Vaccine hesitancy communication: what counts as evidence? Vaccine 36:6529–6530CrossRef
59.
Zurück zum Zitat Rollnick S, Miller WR, Butler CC (2008) Motivational interviewing in health care. helping patients change behavior. The Guilford Press, New York LondonCrossRef Rollnick S, Miller WR, Butler CC (2008) Motivational interviewing in health care. helping patients change behavior. The Guilford Press, New York LondonCrossRef
60.
Zurück zum Zitat Thomson A, Robinson K, Vallée-Tourangeau G (2016) The 5As: a practical taxonomy for the determinants of vaccine uptake. Vaccine 34:1018–1024CrossRef Thomson A, Robinson K, Vallée-Tourangeau G (2016) The 5As: a practical taxonomy for the determinants of vaccine uptake. Vaccine 34:1018–1024CrossRef
61.
Zurück zum Zitat Pebody B (2012) Vaccine registers Experience from Europe and elsewhere. Eurosurv 17:2–4 Pebody B (2012) Vaccine registers Experience from Europe and elsewhere. Eurosurv 17:2–4
62.
Zurück zum Zitat Shen KA, Williams WW, O’Halloran A et al (2018) Promoting adult immunization using population-based data for a composite measure. Am J Prev Med 1:7 Shen KA, Williams WW, O’Halloran A et al (2018) Promoting adult immunization using population-based data for a composite measure. Am J Prev Med 1:7
Metadaten
Titel
Where are the keys to improve vaccine uptake in adults and elders in European countries?
verfasst von
Jacques Gaillat
Publikationsdatum
01.04.2021
Verlag
Springer International Publishing
Erschienen in
Aging Clinical and Experimental Research / Ausgabe 4/2021
Elektronische ISSN: 1720-8319
DOI
https://doi.org/10.1007/s40520-019-01443-9

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

Alternde Blutbildung lässt solide Tumoren wachsen

Bestimmte mutierte Blutzellen erhöhen nicht nur das Risiko für hämatologische Neoplasien, sondern sind offenbar auch bei soliden Tumoren prognostisch ungünstig. Dafür sprechen aktuelle Erkenntnisse, insbesondere beim nichtkleinzelligen Lungenkarzinom.

Erneut Hinweise für Neuroprotektion durch Gürtelroseimpfung

Ergebnisse eines kürzlich publizierten „natürlichen Experiments“ in Wales legten nahe, dass eine Herpes-Zoster-Impfung das Demenzrisiko senkt. Jetzt hat das Studienteam ähnliche Daten aus Australien publiziert, die in die gleiche Richtung zeigen. Offene Fragen bleiben allerdings so oder so.

Harnwegsinfekt mit üblem Verlauf: Das sind die Anzeichen

Harnwegsinfekte können schwer und sogar tödlich verlaufen. Welche Patienten gefährdet sind, ist im Zuge einer Metaanalyse untersucht worden.

Podcast

Leben statt zu Überleben: Post-Intensive-Care-Syndrom

Immer mehr Menschen überleben kritische Erkrankungen. Aber Beatmung, Sedierung und die Eindrücke der Intensivstation hinterlassen Spuren. Das Post-Intensive-Care-Syndrom kann die Folge sein. Es ist nicht nur eine Herausforderung für Kliniken, sondern auch Hausarztpraxen. Mit Allgemeinmediziner Prof. Dr. med. Konrad Schmidt sprechen wir in dieser Folge darüber, wie die Überlebenden wieder ins Leben finden können.

Zeitschrift für Allgemeinmedizin, DEGAM

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.